Know Cancer

or
forgot password

Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004


N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Tumor

Thank you

Trial Information

Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004


Inclusion Criteria:



- Suspicion of pancreatic adenocarcinoma

- Patient > 18 years old

- Social Security affiliation

- Signed informed consent

Exclusion Criteria:

- Patient in emergency situation

- Major person being the object of a legal protective measure or unable to express its
consent

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label

Outcome Measure:

Biomarkers

Outcome Description:

Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers

Outcome Time Frame:

within twenty four hours

Safety Issue:

No

Principal Investigator

Marine GILABERT, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Institut Paoli-Calmettes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

PACAomics / IPC 2011-004

NCT ID:

NCT01692873

Start Date:

February 2012

Completion Date:

February 2015

Related Keywords:

  • Pancreatic Tumor
  • pancreatic tumor
  • Pancreatic Neoplasms

Name

Location